Please login to the form below

Not currently logged in
Email:
Password:

subcutaneous injection

This page shows the latest subcutaneous injection news and features for those working in and with pharma, biotech and healthcare.

AbbVie announces positive results from head-to-head study of Skyrizi in Crohn's disease

AbbVie announces positive results from head-to-head study of Skyrizi in Crohn's disease

The late-stage SEQUENCE study has been evaluating the drugs, both given as a subcutaneous injection every eight weeks after a lead-in period of intravenous infusions, in patients with moderately

Latest news

More from news
Approximately 2 fully matching, plus 108 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    It’s given as a subcutaneous injection that takes less than a minute to deliver every two weeks, around 75% fewer injections than other products for HAE prevention. ... Injection volumes are lower, it can be taken weekly as well as monthly and can be

  • Implementing eHealth innovation Implementing eHealth innovation

    Growth hormone treatment (GHT) is only available on prescription and is given as a subcutaneous injection (directly under the skin). ... complete, partial, missed) of each injection, and uploads this data wirelessly from the patients’ homes to the

  • Deal Watch November 2016 Deal Watch November 2016

    Arsia has a proprietary viscosity reducing technology and know-how to enable the development of high concentration formulations of biologics that can be administered by subcutaneous injection rather than intravenously. ... Invossa, cell-mediated gene

  • Deal Watch July 2016 Deal Watch July 2016

    cells. The product has been submitted to the EMA following a phase III trial showing safety and efficacy of a single injection in the treatment of complex peri-anal fistulas, and ... The presentation is subcutaneous injection in both indications, leaving

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....